MedTrace Logo

Effects of Restylane-L® Filler Injection for Non-Surgical Rhinoplasty

NCT04169308 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-08-13

No results posted yet for this study

Summary

The purpose of this research is to determine the effects of Restylane-L® Filler Injection for Non-Surgical Rhinoplasty on First Impressions and Quality of Life determined by using the FACE-Q Scale.

Secondary objectives include:

To determine the efficacy of Restylane-L® Filler injection to the nose in reduction of convexity of the nasal dorsum as measured on pre/post injection 2D photographs.

To measure changes in nasal projection and rotation after injection with Restylane-L® Filler in subset of patients who underwent nasal tip augmentation.

To determine the safety of Restylane-L® Filler injection to the nose for non-surgical rhinoplasty.

Conditions

  • Deformity of Nasal Cartilage

Interventions

DRUG

Restylane-L® Filler injection

Restylane-L® Filler injection into the soft tissue of the nose

Sponsors & Collaborators

  • Galderma R&D

    collaborator INDUSTRY

  • DeNova Research

    lead OTHER

Principal Investigators

  • Steven Dayan, MD · DeNova Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-07-20
Completion
2020-07-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04169308 on ClinicalTrials.gov